Absci (ABSI) Financials

Absci logo
$8.18 +0.60 (+7.92%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$8.38 +0.20 (+2.49%)
As of 11/18/2026 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Absci

Annual Income Statements for Absci

This table shows Absci's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-49 -103 -105 -111 -103 -115
Consolidated Net Income / (Loss)
-14 -101 -105 -111 -103 -115
Net Income / (Loss) Continuing Operations
-32 -101 -105 -111 -103 -115
Total Pre-Tax Income
-14 -110 -105 -110 -103 -115
Total Operating Income
-13 -75 -107 -116 -109 -120
Total Gross Profit
4.78 4.78 5.75 5.72 4.53 2.80
Total Revenue
4.78 4.78 5.75 5.72 4.53 2.80
Operating Revenue
4.78 4.78 5.75 5.72 4.53 2.80
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses
36 80 112 121 113 123
Selling, General & Admin Expense
5.50 29 41 38 36 35
Research & Development Expense
11 45 59 48 64 81
Depreciation Expense
1.13 6.65 13 14 13 12
Other Operating Expenses / (Income)
18 - - - 0.00 -5.10
Total Other Income / (Expense), net
-1.05 -35 1.39 5.05 5.85 5.20
Interest Expense
0.63 3.43 0.97 1.01 0.57 0.21
Other Income / (Expense), net
-0.42 -31 2.36 6.06 6.42 5.41
Income Tax Expense
0.00 -8.90 -0.46 0.10 0.07 0.07
Basic Earnings per Share
($3.19) ($2.08) ($1.15) ($1.20) ($0.94) ($0.84)
Weighted Average Basic Shares Outstanding
15.49M 49.69M 90.85M 92.03M 110.24M 136.78M
Diluted Earnings per Share
($3.19) ($2.08) ($1.15) ($1.20) ($0.94) ($0.84)
Weighted Average Diluted Shares Outstanding
15.49M 49.69M 90.85M 92.03M 110.24M 136.78M
Weighted Average Basic & Diluted Shares Outstanding
- 92.77M 92.32M 112.78M 127.33M 153.02M

Quarterly Income Statements for Absci

This table shows Absci's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - - - - - - 35
Net Income / (Loss) Attributable to Common Shareholders
-22 -25 -27 -29 -26 -31 -29 -30 -30 -33 -34
Consolidated Net Income / (Loss)
-22 -25 -27 -29 -26 -31 -29 -30 -30 -33 -33
Net Income / (Loss) Continuing Operations
-22 -25 -27 -29 -26 -31 -29 -30 -30 -33 -33
Total Pre-Tax Income
-22 -25 -27 -29 -26 -30 -29 -30 -30 -33 -33
Total Operating Income
-23 -27 -29 -30 -28 -31 -30 -31 -31 -34 -35
Total Gross Profit
0.90 1.27 1.70 0.67 1.18 0.59 0.38 0.65 0.00 0.00 0.00
Total Revenue
0.90 1.27 1.70 0.67 1.18 0.59 0.38 0.65 0.00 0.00 0.00
Operating Revenue
0.90 1.27 1.70 0.67 1.18 0.59 0.38 0.65 0.00 0.00 0.00
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Operating Expenses
24 28 31 30 29 32 31 32 31 34 35
Selling, General & Admin Expense
8.74 9.35 9.26 8.83 9.47 8.53 8.44 8.62 9.06 9.16 9.04
Research & Development Expense
12 15 18 18 16 20 19 25 19 23 24
Depreciation Expense
3.42 3.38 3.36 3.23 3.07 3.00 2.84 2.83 2.73 2.70 2.69
Total Other Income / (Expense), net
1.54 1.97 1.53 0.81 1.38 0.96 1.55 1.32 1.27 0.99 1.71
Interest Expense
0.18 0.15 0.13 0.11 0.08 0.06 0.05 0.03 0.02 0.00 0.00
Other Income / (Expense), net
1.71 2.12 1.66 0.92 1.46 1.01 1.60 1.35 1.28 0.99 1.71
Income Tax Expense
0.01 0.00 0.04 0.02 -0.00 0.13 0.10 -0.16 0.02 0.04 0.02
Basic Earnings per Share
($0.22) ($0.22) ($0.24) ($0.26) ($0.21) ($0.24) ($0.20) ($0.19) ($0.19) ($0.21) ($0.19)
Weighted Average Basic Shares Outstanding
99.39M 112.93M 113.61M 110.24M 124.46M 127.59M 143.77M 136.78M 152.96M 157.47M 171.80M
Diluted Earnings per Share
($0.22) ($0.22) ($0.24) ($0.26) ($0.21) ($0.24) ($0.20) ($0.19) ($0.19) ($0.21) ($0.19)
Weighted Average Diluted Shares Outstanding
99.39M 112.93M 113.61M 110.24M 124.46M 127.59M 143.77M 136.78M 152.96M 157.47M 171.80M
Weighted Average Basic & Diluted Shares Outstanding
113.08M 113.56M 114.86M 127.33M 127.56M 149.52M 150.37M 153.02M 155.91M 171.61M 172.75M

Annual Cash Flow Statements for Absci

This table details how cash moves in and out of Absci's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
58 208 -203 13 -31 -37
Net Cash From Operating Activities
-11 -61 -81 -65 -72 -93
Net Cash From Continuing Operating Activities
-11 -61 -81 -65 -72 -93
Net Income / (Loss) Continuing Operations
-14 -101 -105 -111 -103 -115
Consolidated Net Income / (Loss)
-14 -101 -105 -111 -103 -115
Depreciation Expense
1.13 6.65 13 14 13 12
Amortization Expense
- 0.00 -0.69 -2.67 -3.74 -2.54
Non-Cash Adjustments To Reconcile Net Income
1.24 45 13 33 19 13
Changes in Operating Assets and Liabilities, net
1.01 -12 -1.32 1.85 1.61 -0.16
Net Cash From Investing Activities
-2.17 -67 -127 82 -42 -50
Net Cash From Continuing Investing Activities
-2.17 -67 -127 82 -42 -50
Purchase of Property, Plant & Equipment
-2.18 -38 -16 -0.86 -0.40 -1.11
Purchase of Investments
0.00 -1.20 -109 -147 -186 -120
Sale of Property, Plant & Equipment
0.01 0.00 0.13 0.25 0.94 1.31
Sale and/or Maturity of Investments
- 0.00 5.00 230 144 70
Net Cash From Financing Activities
71 336 5.24 -4.48 83 106
Net Cash From Continuing Financing Activities
71 336 5.24 -4.48 83 106
Repayment of Debt
-0.50 -1.60 -4.65 -3.01 -3.39 -3.12
Issuance of Common Equity
0.00 210 0.66 0.86 87 109
Other Financing Activities, net
-1.09 -2.55 -2.80 -2.33 -0.64 -0.08
Cash Interest Paid
0.51 0.65 0.90 0.97 0.56 0.18

Quarterly Cash Flow Statements for Absci

This table details how cash moves in and out of Absci's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-13 -16 -5.44 3.07 5.91 -8.84 -28 -5.79 -11 99 -95
Net Cash From Operating Activities
-18 -17 -21 -17 -22 -17 -25 -29 -26 -28 -29
Net Cash From Continuing Operating Activities
-18 -17 -21 -17 -22 -17 -25 -29 -26 -28 -29
Net Income / (Loss) Continuing Operations
-22 -25 -27 -29 -26 -31 -29 -30 -30 -33 -33
Consolidated Net Income / (Loss)
-22 -25 -27 -29 -26 -31 -29 -30 -30 -33 -33
Depreciation Expense
3.42 3.38 3.36 3.23 3.07 3.00 2.84 2.83 2.73 2.70 2.69
Amortization Expense
-0.63 -1.21 -1.12 -0.78 -0.70 -0.67 -0.65 -0.53 -0.42 -0.33 -0.58
Non-Cash Adjustments To Reconcile Net Income
3.59 5.28 5.52 5.07 4.91 4.75 4.40 -0.84 4.38 5.24 4.20
Changes in Operating Assets and Liabilities, net
-2.26 0.46 -1.09 4.50 -2.78 6.61 -2.92 -1.08 -3.40 -1.96 -2.47
Net Cash From Investing Activities
-77 1.26 15 19 -15 9.04 -64 20 7.36 24 -67
Net Cash From Continuing Investing Activities
-77 1.26 15 19 -15 9.04 -64 20 7.36 24 -67
Purchase of Property, Plant & Equipment
0.00 -0.33 -0.05 -0.02 -0.03 -0.22 -0.96 0.10 -0.03 -0.00 -0.01
Purchase of Investments
-97 -34 -28 -27 -40 -18 -77 15 -19 -3.96 -94
Sale and/or Maturity of Investments
21 36 43 45 25 26 14 4.31 26 28 27
Net Cash From Financing Activities
81 -0.13 0.49 0.99 43 -1.00 60 3.84 7.56 103 2.02
Net Cash From Continuing Financing Activities
81 -0.13 0.49 0.99 43 -1.00 60 3.84 7.56 103 2.02
Repayment of Debt
-0.87 -0.80 -0.82 -0.90 -0.76 -1.08 -0.78 -0.50 -0.46 -0.26 -0.09
Issuance of Common Equity
82 0.76 1.39 1.95 44 0.10 61 4.34 8.02 103 2.11

Annual Balance Sheets for Absci

This table presents Absci's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
89 426 321 217 214 216
Total Current Assets
73 273 187 121 134 150
Cash & Equivalents
70 253 60 72 41 20
Short-Term Investments
- - 104 25 71 124
Prepaid Expenses
1.77 8.57 5.86 4.54 5.46 5.28
Plant, Property, & Equipment, net
0.00 52 0.00 0.00 29 21
Total Noncurrent Assets
15 101 134 97 51 46
Intangible Assets
0.00 55 52 48 45 42
Other Noncurrent Operating Assets
15 25 61 48 5.73 4.35
Total Liabilities & Shareholders' Equity
89 426 321 217 214 216
Total Liabilities
22 60 47 41 34 27
Total Current Liabilities
10 34 30 30 29 23
Short-Term Debt
1.54 2.40 2.95 16 15 0.87
Accounts Payable
2.12 8.39 2.41 1.50 10 19
Current Deferred Revenue
2.63 1.35 0.45 3.17 1.12 0.74
Other Current Liabilities
2.25 4.29 3.99 2.32 1.61 1.81
Total Noncurrent Liabilities
11 26 16 12 5.82 4.08
Noncurrent Deferred Revenue
- - 0.00 0.97 0.00 0.44
Other Noncurrent Operating Liabilities
4.56 24 7.35 0.30 4.56 3.65
Total Equity & Noncontrolling Interests
-89 366 274 176 179 189
Total Preferred & Common Equity
-89 366 274 176 179 189
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-89 366 274 176 179 189
Common Stock
0.64 557 570 583 689 814
Retained Earnings
-90 -191 -296 -406 -510 -625
Accumulated Other Comprehensive Income / (Loss)
0.00 -0.01 -0.12 -0.04 -0.00 0.59

Quarterly Balance Sheets for Absci

This table presents Absci's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
254 236 275 256 235 232 210 245 196 269 240
Total Current Assets
148 135 182 165 150 156 137 175 132 208 182
Cash & Equivalents
61 70 59 43 38 47 38 9.48 8.63 108 13
Short-Term Investments
64 44 103 102 89 87 79 143 117 93 160
Prepaid Expenses
5.23 4.40 3.86 3.39 5.78 4.54 3.04 5.18 6.27 7.12 8.16
Plant, Property, & Equipment, net
0.00 0.00 39 0.00 0.00 27 0.00 23 19 17 15
Total Noncurrent Assets
106 102 54 90 85 49 72 47 45 44 43
Intangible Assets
50 49 47 47 46 44 43 42 41 40 39
Other Noncurrent Operating Assets
56 53 6.93 44 39 5.40 29 4.63 4.08 3.88 3.59
Total Liabilities & Shareholders' Equity
254 236 275 256 235 232 210 245 196 269 240
Total Liabilities
39 40 35 34 34 34 37 35 24 23 21
Total Current Liabilities
25 28 25 25 27 27 31 30 20 20 19
Short-Term Debt
3.15 3.21 3.30 3.12 3.27 15 15 14 0.41 0.15 0.06
Accounts Payable
1.85 1.91 1.65 1.69 1.67 4.95 8.21 4.59 17 16 16
Current Deferred Revenue
0.50 0.35 3.06 1.97 1.78 1.10 0.95 1.08 0.45 1.15 1.09
Other Current Liabilities
3.28 2.83 1.87 1.82 1.71 1.69 1.71 1.76 1.86 2.04 2.09
Total Noncurrent Liabilities
13 12 9.50 8.57 7.21 6.37 5.20 4.94 3.59 3.19 2.04
Noncurrent Deferred Revenue
- - 0.18 0.00 0.00 - - - 0.64 0.24 0.00
Other Noncurrent Operating Liabilities
6.42 0.00 0.08 0.02 0.03 1.69 1.48 4.88 0.81 2.95 2.04
Total Equity & Noncontrolling Interests
215 196 240 221 201 199 173 210 172 246 219
Total Preferred & Common Equity
215 196 240 221 201 199 173 210 172 246 219
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
215 196 240 221 201 199 173 210 172 246 219
Common Stock
577 579 669 675 682 735 740 805 826 934 940
Retained Earnings
-361 -383 -428 -453 -481 -536 -567 -595 -654 -688 -721
Accumulated Other Comprehensive Income / (Loss)
-0.15 -0.06 -0.13 -0.11 0.25 0.02 0.31 0.50 0.30 0.15 -0.52

Annual Metrics And Ratios for Absci

This table displays calculated financial ratios and metrics derived from Absci's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 92,591,472.00 - - - 150,371,531.00
DEI Adjusted Shares Outstanding
0.00 92,591,472.00 - - - 150,371,531.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -1.12 - - - -0.77
Growth Metrics
- - - - - -
Profitability Metrics
- - - - - -
Net Operating Profit after Tax (NOPAT)
-9.31 -53 -75 -81 -76 -84
Return On Investment Capital (ROIC_SIMPLE)
- - - -39.93% -38.05% -44.25%
Earnings before Interest and Taxes (EBIT)
-14 -106 -104 -109 -102 -115
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-13 -100 -92 -98 -93 -106
Valuation Ratios
- - - - - -
Leverage & Solvency
- - - - - -
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -154 -75 -63 -60 -63
Efficiency Ratios
- - - - - -
Capital & Investment Metrics
- - - - - -
Invested Capital
5.58 107 107 89 72 46
Increase / (Decrease) in Invested Capital
0.00 101 0.09 -18 -17 -21
Book Value per Share
($5.77) $3.95 $2.97 $1.90 $1.56 $1.26
Tangible Book Value per Share
($5.77) $3.13 $2.18 $1.38 $1.17 $0.98
Total Capital
75 370 286 202 200 190
Total Debt
8.44 3.52 12 26 21 0.87
Total Long-Term Debt
6.91 1.12 8.73 10 5.69 0.00
Net Debt
-61 -260 -168 -88 -107 -143
Capital Expenditures (CapEx)
2.17 38 16 0.61 -0.54 -0.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5.19 -21 -20 -6.82 -7.71 -17
Debt-free Net Working Capital (DFNWC)
65 242 160 107 121 128
Net Working Capital (NWC)
63 239 157 91 105 127
Net Nonoperating Expense (NNE)
5.04 48 30 30 27 31
Net Nonoperating Obligations (NNO)
-61 -260 -168 -88 -107 -143
Total Depreciation and Amortization (D&A)
1.13 6.65 12 11 9.65 9.20
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($2.08) ($1.15) ($1.20) ($0.94) ($0.84)
Adjusted Weighted Average Basic Shares Outstanding
0.00 49.69M 90.85M 92.03M 110.24M 136.78M
Adjusted Diluted Earnings per Share
$0.00 ($2.08) ($1.15) ($1.20) ($0.94) ($0.84)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 49.69M 90.85M 92.03M 110.24M 136.78M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 92.77M 92.32M 112.78M 127.33M 153.02M
Normalized Net Operating Profit after Tax (NOPAT)
-9.31 -53 -75 -66 -76 -84
Debt Service Ratios
- - - - - -
Payout Ratios
- - - - - -

Quarterly Metrics And Ratios for Absci

This table displays calculated financial ratios and metrics derived from Absci's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - 127,333,887.00 127,559,352.00 149,522,647.00 150,371,531.00 153,021,263.00 155,905,056.00 171,614,010.00
DEI Adjusted Shares Outstanding
- - - - 127,333,887.00 127,559,352.00 149,522,647.00 150,371,531.00 153,021,263.00 155,905,056.00 171,614,010.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.21 -0.24 -0.19 -0.20 -0.20 -0.21 -0.20
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-29.24% -62.28% 128.63% 96.75% 31.29% -53.31% -77.78% - -100.00% -100.00% -100.00%
EBITDA Growth
6.65% 42.08% -32.62% -30.67% -25.77% -25.07% -5.48% - -14.05% -9.80% -18.25%
EBIT Growth
5.39% 40.59% -25.31% -23.87% -20.58% -23.50% -4.87% - -12.53% -9.17% -16.54%
NOPAT Growth
4.03% 37.84% -24.00% -20.35% -18.01% -17.48% -4.36% - -11.24% -8.81% -16.05%
Net Income Growth
5.91% 40.61% -24.57% -23.10% -19.89% -23.51% -4.77% - -12.35% -8.64% -16.00%
EPS Growth
15.38% 51.11% 0.00% -4.00% 4.55% -9.09% 16.67% - 9.52% 12.50% 5.00%
Operating Cash Flow Growth
11.21% 12.43% -100.10% -13.68% -22.26% -0.18% -20.74% - -20.46% -63.36% -17.72%
Free Cash Flow Firm Growth
188.33% 52.72% -143.44% -701.54% -164.05% -100.58% -12.01% - 87.44% -22.55% -73.09%
Invested Capital Growth
-33.51% -16.69% -15.98% -18.85% -7.87% -18.37% -19.06% - -28.95% -22.38% -19.11%
Revenue Q/Q Growth
165.68% 41.43% 33.94% -60.91% 77.29% -49.70% -36.26% - -100.00% 0.00% 0.00%
EBITDA Q/Q Growth
5.95% -18.03% -11.44% -5.63% 9.48% -17.38% 6.02% - 0.50% -13.00% -1.22%
EBIT Q/Q Growth
6.47% -12.91% -10.70% -5.96% 8.95% -15.65% 6.01% - 0.44% -12.19% -0.34%
NOPAT Q/Q Growth
5.02% -13.72% -8.14% -3.04% 6.87% -13.21% 3.95% - 0.63% -10.74% -2.45%
Net Income Q/Q Growth
6.67% -12.63% -10.70% -5.79% 9.10% -16.03% 6.09% - -0.13% -12.20% -0.27%
EPS Q/Q Growth
12.00% 0.00% -9.09% -8.33% 19.23% -14.29% 16.67% - 0.00% -10.53% 9.52%
Operating Cash Flow Q/Q Growth
-19.71% 5.71% -23.09% 18.17% -28.74% 22.74% -48.35% - 9.85% -4.78% -6.90%
Free Cash Flow Firm Q/Q Growth
11.25% -120.96% -61.33% 42.14% -227.34% 34.36% 9.91% - -559.76% -540.72% -27.24%
Invested Capital Q/Q Growth
6.07% -4.48% -3.51% 4.63% -4.47% -15.37% -4.32% - 6.07% -7.55% -0.29%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 0.00% 0.00% 0.00%
EBITDA Margin
-2,116.04% -1,765.98% -1,469.37% -3,970.08% -2,026.97% -4,730.35% -6,974.34% - 0.00% 0.00% 0.00%
Operating Margin
-2,616.70% -2,104.02% -1,698.71% -4,477.29% -2,351.91% -5,293.93% -7,977.25% - 0.00% 0.00% 0.00%
EBIT Margin
-2,426.17% -1,937.01% -1,600.88% -4,338.80% -2,228.24% -5,123.44% -7,554.76% - 0.00% 0.00% 0.00%
Profit (Net Income) Margin
-2,447.10% -1,948.82% -1,610.70% -4,358.35% -2,234.61% -5,154.97% -7,594.18% - 0.00% 0.00% 0.00%
Tax Burden Percent
100.05% 100.00% 100.14% 100.07% 99.98% 100.43% 100.36% - 100.06% 100.12% 100.05%
Interest Burden Percent
100.81% 100.61% 100.48% 100.38% 100.30% 100.18% 100.16% - 100.06% 100.01% 100.01%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-104.88% -61.07% -66.45% -177.00% -110.64% -237.01% -252.74% - 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-101.29% -56.75% -60.65% -168.64% -105.94% -230.54% -247.45% - 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
63.00% 36.39% 37.69% 92.43% 71.35% 154.99% 172.69% - 0.00% 0.00% 0.00%
Return on Equity (ROE)
-41.88% -24.68% -28.76% -84.57% -39.28% -82.02% -80.06% - 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)
-45.60% -69.55% -79.20% -74.13% -102.32% -107.22% -112.93% - -113.17% -145.84% -161.13%
Operating Return on Assets (OROA)
-45.46% -24.70% -28.56% -91.31% -42.29% -91.10% -88.57% - 0.00% 0.00% 0.00%
Return on Assets (ROA)
-45.85% -24.85% -28.74% -91.72% -42.42% -91.66% -89.03% - 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
-41.88% -24.68% -28.76% -84.57% -39.28% -82.02% -80.06% - 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
-45.47% -41.66% -48.51% 0.00% -54.06% 0.00% 0.00% - 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-16 -19 -20 -21 -19 -22 -21 -22 -22 -24 -24
NOPAT Margin
-1,831.69% -1,472.81% -1,189.09% -3,134.11% -1,646.34% -3,705.75% -5,584.07% - 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-3.60% -4.32% -5.80% -8.36% -4.69% -6.47% -5.29% - -6.32% -5.88% -5.36%
Return On Investment Capital (ROIC_SIMPLE)
- - - -10.41% -8.87% -11.46% -9.40% -11.42% -12.37% -9.71% -11.20%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
973.72% 735.91% 544.15% 1,327.52% 803.39% 1,438.11% 2,233.07% - 0.00% 0.00% 0.00%
R&D to Revenue
1,362.58% 1,201.65% 1,057.32% 2,763.46% 1,387.96% 3,449.92% 5,092.33% - 0.00% 0.00% 0.00%
Operating Expenses to Revenue
2,716.70% 2,204.02% 1,798.71% 4,577.29% 2,451.91% 5,393.93% 8,077.25% - 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-22 -25 -27 -29 -26 -30 -29 -30 -30 -33 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-19 -22 -25 -26 -24 -28 -26 -27 -27 -31 -31
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.67 1.57 2.15 1.68 1.61 1.89 2.16 - 2.67 7.34 8.45
Price to Tangible Book Value (P/TBV)
3.32 1.99 2.79 2.24 2.07 2.52 2.71 - 3.50 8.77 10.31
Price to Revenue (P/Rev)
119.81 107.17 103.11 66.37 66.38 79.22 161.47 - 283.20 1,757.72 2,843.51
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
6.37 2.78 4.38 2.69 2.76 3.66 5.39 - 6.88 35.58 37.21
Enterprise Value to Revenue (EV/Rev)
88.85 60.94 71.59 42.73 39.36 51.38 106.52 - 207.23 1,562.21 2,576.33
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.05 0.05 0.05 0.12 0.10 0.11 0.07 - 0.01 0.00 0.00
Long-Term Debt to Equity
0.04 0.04 0.03 0.03 0.02 0.02 0.00 - 0.01 0.00 0.00
Financial Leverage
-0.62 -0.64 -0.62 -0.55 -0.67 -0.67 -0.70 - -0.68 -0.75 -0.77
Leverage Ratio
1.16 1.17 1.19 1.21 1.16 1.18 1.17 - 1.15 1.14 1.13
Compound Leverage Factor
1.16 1.17 1.19 1.22 1.16 1.18 1.17 - 1.16 1.14 1.13
Debt to Total Capital
4.90% 4.94% 4.86% 10.57% 9.13% 9.62% 6.29% - 1.47% 0.06% 0.03%
Short-Term Debt to Total Capital
1.31% 1.34% 1.55% 7.73% 6.99% 7.68% 6.26% - 0.24% 0.06% 0.03%
Long-Term Debt to Total Capital
3.59% 3.60% 3.31% 2.84% 2.14% 1.94% 0.03% - 1.23% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Common Equity to Total Capital
95.10% 95.06% 95.14% 89.43% 90.87% 90.38% 93.71% - 98.53% 99.94% 99.97%
Debt to EBITDA
-0.13 -0.14 -0.12 -0.23 -0.20 -0.18 -0.13 - -0.02 0.00 0.00
Net Debt to EBITDA
1.71 1.87 1.53 1.15 1.33 1.11 1.48 - 1.13 1.80 1.49
Long-Term Debt to EBITDA
-0.09 -0.10 -0.08 -0.06 -0.05 -0.04 0.00 - -0.02 0.00 0.00
Debt to NOPAT
-0.15 -0.17 -0.14 -0.28 -0.25 -0.22 -0.17 - -0.03 0.00 0.00
Net Debt to NOPAT
2.06 2.18 1.82 1.41 1.64 1.40 1.86 - 1.43 2.28 1.89
Long-Term Debt to NOPAT
-0.11 -0.12 -0.10 -0.07 -0.06 -0.05 0.00 - -0.02 0.00 0.00
Altman Z-Score
9.31 4.01 5.08 2.06 2.78 1.76 4.81 - 7.17 44.44 49.22
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
7.19 6.49 5.63 4.67 5.72 4.39 5.89 - 6.59 10.63 9.64
Quick Ratio
6.39 5.71 4.82 3.92 4.96 3.77 5.17 - 6.28 10.26 9.21
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
21 -4.43 -7.15 -4.14 -14 -8.89 -8.01 -0.26 -1.70 -11 -14
Operating Cash Flow to CapEx
0.00% -5,057.96% 0.00% 0.00% 0.00% 0.00% -2,601.98% - -101,180.77% 0.00% -327,411.11%
Free Cash Flow to Firm to Interest Expense
120.13 -29.54 -55.00 -37.95 -171.41 -158.73 -177.95 - -94.46 -5,446.80 -6,930.40
Operating Cash Flow to Interest Expense
-101.49 -112.29 -159.48 -155.63 -276.44 -301.30 -556.24 - -1,461.50 -13,782.00 -14,733.50
Operating Cash Flow Less CapEx to Interest Expense
-100.65 -114.51 -159.12 -149.47 -275.33 -286.18 -577.62 - -1,462.94 -13,761.50 -14,738.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.02 0.01 0.02 0.02 0.02 0.02 0.01 - 0.01 0.00 0.00
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Fixed Asset Turnover
0.12 0.00 0.00 0.00 0.15 0.00 0.00 - 0.07 0.00 0.03
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
75 71 69 72 69 58 56 46 49 45 45
Invested Capital Turnover
0.06 0.04 0.06 0.06 0.07 0.06 0.05 - 0.03 0.02 0.01
Increase / (Decrease) in Invested Capital
-38 -14 -13 -17 -5.87 -13 -13 -21 -20 -13 -11
Enterprise Value (EV)
475 198 301 194 190 213 300 - 336 1,606 1,675
Market Capitalization
641 348 434 301 320 328 455 - 459 1,807 1,848
Book Value per Share
$2.13 $1.96 $1.77 $1.56 $1.56 $1.36 $1.41 $1.26 $1.12 $1.58 $1.27
Tangible Book Value per Share
$1.71 $1.55 $1.37 $1.17 $1.22 $1.02 $1.12 $0.98 $0.86 $1.32 $1.05
Total Capital
252 233 212 200 219 192 224 190 175 246 219
Total Debt
12 12 10 21 20 18 14 0.87 2.56 0.15 0.06
Total Long-Term Debt
9.07 8.38 7.00 5.69 4.69 3.71 0.07 0.00 2.15 0.00 0.00
Net Debt
-166 -150 -133 -107 -130 -115 -155 -143 -123 -201 -174
Capital Expenditures (CapEx)
-0.15 0.33 -0.05 -0.67 -0.09 -0.85 0.96 -0.23 0.03 -0.04 0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-18 -19 -16 -7.71 -6.07 -13 -9.48 -17 -13 -12 -11
Debt-free Net Working Capital (DFNWC)
160 143 127 121 144 121 159 128 112 189 163
Net Working Capital (NWC)
157 140 123 105 129 106 145 127 112 189 163
Net Nonoperating Expense (NNE)
5.53 6.05 7.17 8.14 6.94 8.59 7.60 7.83 8.01 9.30 8.80
Net Nonoperating Obligations (NNO)
-166 -150 -133 -107 -130 -115 -155 -143 -123 -201 -174
Total Depreciation and Amortization (D&A)
2.79 2.17 2.24 2.45 2.37 2.33 2.19 2.30 2.31 2.37 2.11
Debt-free, Cash-free Net Working Capital to Revenue
-338.17% -581.88% -383.58% -170.14% -126.02% -310.54% -336.59% - -823.57% -1,198.83% -1,636.31%
Debt-free Net Working Capital to Revenue
2,988.80% 4,395.17% 3,012.36% 2,661.18% 2,990.47% 2,919.70% 5,660.46% - 6,931.22% 18,367.51% 25,091.23%
Net Working Capital to Revenue
2,927.06% 4,299.05% 2,934.54% 2,319.70% 2,672.83% 2,563.58% 5,161.14% - 6,905.74% 18,352.92% 25,081.85%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.22) ($0.22) ($0.24) ($0.26) ($0.21) ($0.24) ($0.20) ($0.19) ($0.19) ($0.21) ($0.19)
Adjusted Weighted Average Basic Shares Outstanding
99.39M 112.93M 113.61M 110.24M 124.46M 127.59M 143.77M 136.78M 152.96M 157.47M 171.80M
Adjusted Diluted Earnings per Share
($0.22) ($0.22) ($0.24) ($0.26) ($0.21) ($0.24) ($0.20) ($0.19) ($0.19) ($0.21) ($0.19)
Adjusted Weighted Average Diluted Shares Outstanding
99.39M 112.93M 113.61M 110.24M 124.46M 127.59M 143.77M 136.78M 152.96M 157.47M 171.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
113.08M 113.56M 114.86M 127.33M 127.56M 149.52M 150.37M 153.02M 155.91M 171.61M 172.75M
Normalized Net Operating Profit after Tax (NOPAT)
-16 -19 -20 -21 -19 -22 -21 -22 -22 -24 -24
Normalized NOPAT Margin
-1,831.69% -1,472.81% -1,189.09% -3,134.11% -1,646.34% -3,705.75% -5,584.07% - 0.00% 0.00% 0.00%
Pre Tax Income Margin
-2,445.77% -1,948.82% -1,608.52% -4,355.19% -2,234.94% -5,132.88% -7,566.67% - 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-123.79 -164.00 -209.47 -264.71 -332.54 -542.54 -634.60 - -1,642.39 -16,584.00 -16,640.00
NOPAT to Interest Expense
-93.46 -124.70 -155.59 -191.21 -245.70 -392.41 -469.06 - -1,199.57 -11,955.30 -12,247.90
EBIT Less CapEx to Interest Expense
-122.94 -166.22 -209.11 -258.54 -331.43 -527.41 -655.98 - -1,643.83 -16,563.50 -16,644.50
NOPAT Less CapEx to Interest Expense
-92.61 -126.92 -155.23 -185.04 -244.59 -377.29 -490.44 - -1,201.01 -11,934.80 -12,252.40
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Absci’s financial statements show a well-funded but still pre-commercial biotechnology company. The company has maintained substantial liquidity, but it continues to generate minimal or no revenue while recording sizable operating losses and negative operating cash flow.

  • Liquidity improved sharply in Q2 2026. Cash and equivalents rose from $8.6 million at the end of Q1 to $107.9 million, while short-term investments totaled $93.3 million. Combined cash and short-term investments were approximately $201.1 million at June 30, 2026.
  • Recent financing significantly strengthened the balance sheet. Absci raised approximately $103.0 million through common equity issuance in Q2 2026, following $8.0 million in Q1. This helped increase total assets from $195.6 million to $268.9 million during the quarter.
  • Debt exposure is relatively low. Total liabilities were $22.8 million in Q2 2026, including only $150,000 of short-term debt. The company’s large cash and investment balances provide considerable coverage relative to its debt obligations.
  • Near-term liquidity appears adequate for continued research investment. Q2 operating cash outflow was $27.6 million. Comparing this quarterly burn rate with roughly $201 million of cash and short-term investments suggests a substantial cash runway, although actual runway will depend on future spending, financing and investment activity.

Neutral trends: Absci’s cash management has involved frequent purchases and sales of short-term investments. In Q2 2026, investment maturities and sales generated $28.0 million, offsetting $4.0 million of new investment purchases. This supports liquidity, but investment activity rather than operating revenue has been a major source of cash movement.

  • Equity has increased, but largely because of capital raises. Total common equity rose to $246.1 million in Q2 2026 from $172.0 million in Q1. However, this increase reflects new share issuance rather than profits, and the company continues to carry a large accumulated retained-earnings deficit of $687.6 million.
  • Revenue has deteriorated and reached zero in 2026. Quarterly revenue was $1.7 million in Q3 2024, $1.2 million in Q1 2025 and $650,000 in Q4 2025, before falling to zero in both Q1 and Q2 2026. The lack of current revenue leaves Absci dependent on outside financing and future commercial or partnership milestones.
  • Losses remain persistent. Net losses were $33.2 million in Q2 2026 and $30.0 million in Q1, compared with losses of approximately $28.7 million to $30.6 million in most quarters of 2025. Basic and diluted loss per share was negative $0.21 in Q2.
  • Operating expenses are rising despite the absence of revenue. Total operating expenses increased to $34.5 million in Q2 2026 from $31.1 million in Q1. Research and development expense climbed to $22.6 million from $19.3 million, indicating continued heavy investment in the pipeline without corresponding revenue generation.
  • Operating cash flow remains consistently negative. Absci used $27.6 million in operating activities in Q2 2026, following outflows of $26.3 million in Q1, $29.2 million in Q4 2025 and $25.0 million in Q3. This recurring burn means the company must eventually rely on its cash reserves, asset sales or additional financing.
  • Shareholder dilution is an important risk. Weighted-average basic shares increased from approximately 110.2 million in Q4 2024 to 157.5 million in Q2 2026. The recent $103.0 million equity raise improves liquidity but further increases the number of shares competing for any future earnings.
  • Profitability remains dependent on future execution. Absci has not produced a positive operating income quarter in the supplied period. Its accumulated retained-earnings deficit and ongoing losses indicate that investors are primarily funding a long-term research and development opportunity rather than an established earnings stream.
11/19/26 03:01 AM ETAI Generated. May Contain Errors.

Absci Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Absci's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Absci's net income appears to be on a downward trend, with a most recent value of -$115.18 million in 2025, falling from -$14.35 million in 2020. The previous period was -$103.11 million in 2024. Find out what analysts predict for Absci in the coming months.

Absci's total operating income in 2025 was -$120.32 million, based on the following breakdown:
  • Total Gross Profit: $2.80 million
  • Total Operating Expenses: $123.12 million

Over the last 5 years, Absci's total revenue changed from $4.78 million in 2020 to $2.80 million in 2025, a change of -41.4%.

In the past 13 quarters, Absci's cash and equivalents has ranged from $8.63 million in Q1 2026 to $107.87 million in Q2 2026, and is currently $13.36 million as of their latest financial filing in Q3 2026.

Absci had total debt of $873 thousand at the end of 2025, a 95.9% decrease from 2024, and a 89.7% decrease since 2020.

Over the last 5 years, Absci's book value per share changed from -5.77 in 2020 to 1.26 in 2025.



Financial statements for NASDAQ:ABSI last updated on 11/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners